{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fcua.simplecast.com%2Fepisodes%2Fmilestones-in-advanced-bladder-cancer-NVUuWIgM","width":444,"version":"1.0","type":"rich","title":"Milestones in Advanced Bladder Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/40e324e4-37cd-499e-8e40-fe60892c64a7/389103f6-e311-44b0-ba7f-29459207a502/cua-crest-logo-2019-final.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/46b14298-fdf9-4366-baa1-465ca87c9e64\" height=\"200\" width=\"100%\" title=\"Milestones in Advanced Bladder Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast, Dr. Nimira Alimohamed and Dr. Aly-Khan Lalani review the recent data from trials in advanced bladder cancer including the 5-year survival update of the KEYNOTE-045 trial presented at ASCO in June 2021. The hosts will discuss the impact of immunotherapy and other novel therapeutic strategies on the management of patients with advanced bladder cancer in Canada."}